supply of coronary drug eluting stents,srph153047-coronary drug eluting stents with (1) cobalt chromium alloy (2) coating of bioabsorbable polymer carrier with abluminal and gradient coating for a ctive drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diame ter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 m m. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compa tible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent sho uld be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosi s (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed s cientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy fo r high bleeding risk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major gover nment institute. bis standards for the drug eluting stent are not available. (referen ce:bis catalogue ). unit: no.